Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-GNA13 Antibody (R2F39)

Catalog #:   RHG78402 Specific References (12) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: IHC, WB
Accession: Q14344
Overview

Catalog No.

RHG78402

Species reactivity

Human

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

IHC: 1:100-1:200, WB: 1:1000-1:2000

Target

GNA13, G alpha-13, G-protein subunit alpha-13, Guanine nucleotide-binding protein subunit alpha-13

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q14344

Applications

IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.

Clone ID

R2F39

Data Image
  • Western blot
    Western blot analysis of GNA13 expression in HepG2 cell lysate.
References

Interim PET after 4 cycles predicts outcome in histomolecularly confirmed primary mediastinal B-cell lymphoma., PMID:40030008

Multi-omics analysis and response prediction of PD-1 monoclonal antibody containing regimens in patients with relapsed/refractory diffuse large B-cell lymphoma., PMID:39358470

Case report: Clinicopathological and molecular characteristics of pediatric-type follicular lymphoma., PMID:37539011

Trastuzumab-induced upregulation of a protein set in extracellular vesicles emitted by ErbB2-positive breast cancer cells correlates with their trastuzumab sensitivity., PMID:33023655

Overproduction of inter-α-trypsin inhibitor heavy chain 1 after loss of Gα13 in liver exacerbates systemic insulin resistance in mice., PMID:31597753

Analysis of Genomic Alteration in Primary Central Nervous System Lymphoma and the Expression of Some Related Genes., PMID:30227305

Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical trial cohort., PMID:28302137

Molecular Pathogenesis of Diffuse Large B-Cell Lymphoma., PMID:27980305

GNA13 loss in germinal center B cells leads to impaired apoptosis and promotes lymphoma in vivo., PMID:26989201

Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study., PMID:26819451

The presence of genomic imbalances is associated with poor outcome in patients with burkitt lymphoma treated with dose-intensive chemotherapy including rituximab., PMID:26567765

Breast cancer cell invasion mediated by Gα12 signaling involves expression of interleukins-6 and -8, and matrix metalloproteinase-2., PMID:24976858

Datasheet

Document Download

Anti-GNA13 Antibody (R2F39).pdf

 

$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-GNA13 Antibody (R2F39) [RHG78402]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only